Abstract:STUDY QUESTION
Does sexual intercourse enhance the cycle fecundability in women without known subfertility?
SUMMARY ANSWER
Sexual intercourse (regardless of timing during the cycle) was associated with cycle characteristics suggesting higher fecundability, including longer luteal phase, less premenstrual spotting, and more than two days of cervical fluid with estrogen-stimulated qualities.
… Show more
“…Our results build on prior work evaluating the menstrual cycle characteristics of women using period tracking apps. The median cycle length, 28.7 days in our study, is consistent with previous studies and period tracking app data 17,[20][21][22][23][24] .…”
Section: Discussionsupporting
confidence: 92%
“…The copyright holder for this preprint this version posted October 21, 2022. ; https://doi.org/10.1101/2022.10.20.22280407 doi: medRxiv preprint using period tracking apps. The median cycle length, 28.7 days in our study, is consistent with previous studies and period tracking app data 17,[20][21][22][23][24] . Somatic symptoms were reported most frequently, with cramps being the most reported symptom.…”
Section: (Which Was Not Certified By Peer Review)supporting
ObjectiveTo investigate symptomatology throughout the menstrual cycle, including the frequency of symptoms reported for each phase of the cycle and the relationship between symptoms and individual characteristics.MethodsThis study included self-reported cycle information and symptoms during ovulatory menstrual cycles in mobile application users. Symptom frequency was described overall, by phase, and by day. Relationships between symptoms and individual characteristics (age, body mass index) were tested with logistic regression.Results224,676 unique users and 498,126 unique cycles were included in the analysis. Somatic symptoms were most frequently reported, logged in 85.3% of cycles. Of total symptoms logged, somatic, gastrointestinal, and negative mood symptoms were most prevalent in the late luteal and bleeding days, while positive mood and discharge were most common in the fertile window. Symptom experience differed by age.ConclusionsMenstrual cycle-related symptoms are very common and vary throughout the cycle phases. While most women report negative symptoms including pain, bloating, and negative mood, women also report positive symptoms such as energetic and happy mood. Self-reported data from cycle tracking and health apps can improve our understanding of the prevalence and variability of menstrual-related symptoms.Funding SourceFlo Health UK LimitedPrecisMenstrual symptoms include both positive and negative physical and mood symptoms and differ by age.
“…Our results build on prior work evaluating the menstrual cycle characteristics of women using period tracking apps. The median cycle length, 28.7 days in our study, is consistent with previous studies and period tracking app data 17,[20][21][22][23][24] .…”
Section: Discussionsupporting
confidence: 92%
“…The copyright holder for this preprint this version posted October 21, 2022. ; https://doi.org/10.1101/2022.10.20.22280407 doi: medRxiv preprint using period tracking apps. The median cycle length, 28.7 days in our study, is consistent with previous studies and period tracking app data 17,[20][21][22][23][24] . Somatic symptoms were reported most frequently, with cramps being the most reported symptom.…”
Section: (Which Was Not Certified By Peer Review)supporting
ObjectiveTo investigate symptomatology throughout the menstrual cycle, including the frequency of symptoms reported for each phase of the cycle and the relationship between symptoms and individual characteristics.MethodsThis study included self-reported cycle information and symptoms during ovulatory menstrual cycles in mobile application users. Symptom frequency was described overall, by phase, and by day. Relationships between symptoms and individual characteristics (age, body mass index) were tested with logistic regression.Results224,676 unique users and 498,126 unique cycles were included in the analysis. Somatic symptoms were most frequently reported, logged in 85.3% of cycles. Of total symptoms logged, somatic, gastrointestinal, and negative mood symptoms were most prevalent in the late luteal and bleeding days, while positive mood and discharge were most common in the fertile window. Symptom experience differed by age.ConclusionsMenstrual cycle-related symptoms are very common and vary throughout the cycle phases. While most women report negative symptoms including pain, bloating, and negative mood, women also report positive symptoms such as energetic and happy mood. Self-reported data from cycle tracking and health apps can improve our understanding of the prevalence and variability of menstrual-related symptoms.Funding SourceFlo Health UK LimitedPrecisMenstrual symptoms include both positive and negative physical and mood symptoms and differ by age.
“…The similar enrichment patterns when partitioning heritability for UL and that of sexual factors further elucidate potential overlapped etiology related to the immune system. A chronically active inflammatory immune system is suggested to be involved in UL formation [ 45 , 46 ], and sexual factors are linked to sex hormones [ 6 , 7 ] which have well-established impacts on immune responses [ 47 ]. Future work is warranted to fully uncover specific pathways that underlie the UL-AFS/NSP biological associations.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, sexual factors such as age at first sexual intercourse (AFS) and lifetime number of sexual partners (NSP) receive little empirical attention, even with a decrease in AFS and an increase in NSP being observed in many contemporary societies [3][4][5]. In addition to impacting ovulation and hormonal concentrations [6,7], sexual factors may expose participants to infectious agents in the uterus [8,9]. Therefore, low AFS or high NSP may correlate with alterations in sex hormones and/or an increased susceptibility to uterine infections, both of which have previously been hypothesized to play an etiologic role in UL pathogenesis [10][11][12][13][14].…”
Age at first sexual intercourse (AFS) and lifetime number of sexual partners (NSP) may influence the pathogenesis of uterine leiomyoma (UL) through their associations with hormonal concentrations and uterine infections. Leveraging summary statistics from large-scale genome-wide association studies conducted in European ancestry for each trait (NAFS = 214,547; NNSP = 370,711; NUL = 302,979), we observed a significant negative genomic correlation for UL with AFS (rg = –0.11, P = 7.83×10−4), but not with NSP (rg = 0.01, P = 0.62). Four specific genomic regions were identified as contributing significant local genetic correlations to AFS and UL, including one genomic region further identified for NSP and UL. Partitioning SNP-heritability with cell-type-specific annotations, a close clustering of UL with both AFS and NSP was identified in immune and blood-related components. Cross-trait meta-analysis revealed 15 loci shared between AFS/NSP and UL, including 7 novel SNPs. Univariable two-sample Mendelian randomization (MR) analysis suggested no evidence for a causal association between genetically predicted AFS/NSP and risk of UL, nor vice versa. Multivariable MR adjusting for age at menarche or/and age at natural menopause revealed a significant causal effect of genetically predicted higher AFS on a lower risk of UL. Such effect attenuated to null when age at first birth was further included. Utilizing participant-level data from the UK Biobank, one-sample MR based on genetic risk scores yielded consistent null findings among both pre-menopausal and post-menopausal females. From a genetic perspective, our study demonstrates an intrinsic link underlying sexual factors (AFS and NSP) and UL, highlighting shared biological mechanisms rather than direct causal effects. Future studies are needed to elucidate the specific mechanisms involved in the shared genetic influences and their potential impact on UL development.
“…In a study that included 581 women who contributed 3324 cycles, the majority were <30 years of age (74.5%), non-Hispanic white (88.6%), and nulliparous (70.4%). The mean menses length was 6.2 days (SD = 1.5, range 3-15), and 11.6% of all participants experienced a >3-day difference between the longest and shortest menses length [42]. The study by Park et al reported an average duration of bleeding of 5.6 days; 95.2% reported bleeding between 2 and 7 days and 4.8% reported more than 8 days of bleeding [43].…”
Most published research focuses on the amount of menstrual blood loss and, to a lesser extent, on cyclicity. Little attention has been paid to the duration of bleeding, the factors that enable its cessation within a ‘normal’ timeframe, or to patterns that entail interruption and resumption of blood loss. The definition of what constitutes normal remains arbitrary and there is no therapy specifically designed to shorten the duration of bleeding. Here, we critically review the literature that addresses the duration of bleeding and the factors that trigger endometrial breakdown and repair. Available reports used population averages which mask inter- and intra-individual variations. The duration of bleeding is not necessarily linked to the amount of loss but may be influenced by age, ethnicity, habitus, region and altitude of residence, dieting and stress. The onset of bleeding has been linked to declining steroid production by the corpus luteum. There remains considerable controversy around the extent of endometrial shedding at menstruation. This is likely to vary within and between women. The significance of a change from previous patterns, very short or prolonged bleeding, days of light loss or spotting before or after days of bleeding, or of bleed-free days that punctuate flow, remain poorly understood.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.